FDA approves GSK's BENLYSTA as the first medicine for adult pati
GSK: GlaxoSmithKline (GSK)
2020-12-17 08:59:00
FDA approves GSK's BENLYSTA as the first medicine for adult patients with active lupus nephritis in the US
2020-12-17 08:59:00
FDA approves GSK's BENLYSTA as the first medicine for adult patients with active lupus nephritis in the US
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.